| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_936e13a23675069bcdb004530985fd59 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C65-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C65-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-15 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C55-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f729d421b0ef94c44a9a3226d9ad2b04 |
| publicationDate |
2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019190823-A1 |
| titleOfInvention |
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine |
| abstract |
The application relates to pharmaceutically acceptable salts of [3-(4- {2-butyl-l-[4-(4-chloro-phenoxy)-phenyl]-lH-imidazol-4-yl}-phenoxy) -propyl]-diethylamine (Azeliragon) useful in the treatment of RAGE mediated diseases such as Alzheimer's. |
| priorityDate |
2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |